Metraipolis › archive › dc_686477aa774e
Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial:… — Europe PMC PMID:41674232
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41674232
- DOI
- 10.1111/aos.70106
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T22:15:08.732Z
- SHA-256 of the archived text
9df244b80114c9d2050d9ca97db964c306d0c6faa823489964d06bbe8f9c5050- Stable URL of this page
https://metraipolis.com/documento/dc_686477aa774e
How to cite
Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial:… — Europe PMC PMID:41674232 — Europe PMC (en), https://europepmc.org/article/MED/41674232 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_686477aa774e (Metraipolis archive dc_686477aa774e, sha256 9df244b80114c9d2050d9ca97db964c306d0c6faa823489964d06bbe8f9c5050)
BibTeX
@misc{dc686477aa774e,
title = {Long-term follow-up of chronic central serous chorioretinopathy patients receiving oral eplerenone and half-dose photodynamic therapy in the SPECTRA trial:… — Europe PMC PMID:41674232},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41674232},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_686477aa774e; sha256 9df244b80114c9d2050d9ca97db964c306d0c6faa823489964d06bbe8f9c5050},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41674232. Agents can read the archived copy with the MCP tool read_document.